Near haploidization is a genomic hallmark which defines a molecular subgroup of giant cell glioblastoma. Issue 1 (12th November 2020)

• Record Type: Journal Article
• Authors: Baker, Tiffany G; Alden, Jay; Dubuc, Adrian M; Welsh, Cynthia T; Znoyko, Iya; Cooley, Linda D; Farooqi, Midhat S; Schwartz, Stuart; Li, Yvonne Y; Cherniack, Andrew D; Lindhorst, Scott M; Gener, Melissa; Wolff, Daynna J; Meredith, David M
• Is Part Of: Neuro-oncology advances. Volume 2:Issue 1(2020)
• Publication Date: 2020-11-12
• Subjects: giant cell glioblastoma -- glioblastoma -- loss of heterozygosity -- near haploidization; 616.99481
• DOI: 10.1093/noajnl/vdaa155
• Languages: English
• ISSNs: 2632-2498

Abstract

Abstract: Background: Giant cell glioblastoma (gcGBM) is a rare histologic subtype of glioblastoma characterized by numerous bizarre multinucleate giant cells and increased reticulin deposition. Compared with conventional isocitrate dehydrogenase (IDH)-wildtype glioblastomas, gcGBMs typically occur in younger patients and are generally associated with an improved prognosis. Although prior studies of gcGBMs have shown enrichment of genetic events, such as TP53 alterations, no defining aberrations have been identified. The aim of this study was to evaluate the genomic profile of gcGBMs to facilitate more accurate diagnosis and prognostication for this entity. Methods: Through a multi-institutional collaborative effort, we characterized 10 gcGBMs by chromosome studies, single nucleotide polymorphism microarray analysis, and targeted next-generation sequencing. These tumors were subsequently compared to the genomic and epigenomic profile of glioblastomas described in The Cancer Genome Atlas (TCGA) dataset. Results: Our analysis identified a specific pattern of genome-wide massive loss of heterozygosity (LOH) driven by near haploidization in a subset of glioblastomas with giant cell histology. We compared the genomic signature of these tumors against that of all glioblastomas in the TCGA dataset ( n = 367) and confirmed that our cohort of gcGBMs demonstrated a significantly different genomic profile. Integrated genomic and histologic review of the TCGA cohort identified 3 additional gcGBMs with a near haploid genomic profile. Conclusions: Massive LOH driven by haploidization represents a defining molecular hallmark of a subtype of gcGBM. This unusual mechanism of tumorigenesis provides a diagnostic genomic hallmark to evaluate in future cases, may explain reported differences in survival, and suggests new therapeutic vulnerabilities.